Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped

Research output: Contribution to journal › Article › Academic › peer-review

@article{798b270649b945a390a987827870ebce,

title = "Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped",

author = "T. Rispens and A. Vennegoor and G.J. Wolbink and C.H. Polman and J. Killestein",

year = "2012",

doi = "10.1177/1352458511431073",

language = "Undefined/Unknown",

volume = "18",

pages = "899--901",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "6",

}

TY - JOUR

T1 - Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped

AU - Rispens, T.

AU - Vennegoor, A.

AU - Wolbink, G.J.

AU - Polman, C.H.

AU - Killestein, J.

PY - 2012

Y1 - 2012

U2 - 10.1177/1352458511431073

DO - 10.1177/1352458511431073

M3 - Article

C2 - 22183929

VL - 18

SP - 899

EP - 901

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 6

ER -